Sirds, plaušu un asinsvadu ķirurģija (bērniem)
Hemostāzes kontrole un optimizācija
Antifibrinolītiskie līdzekļi
Avoiding transfusions in children undergoing cardiac surgery: a meta-analysis of randomized trials of aprotinin. (opens new window)
Avots: Anesth Analg 2006;102(3):731-7.
Raksts indeksēts: PubMed 16492820
DOI: 10.1213/01.ane.0000194954.64293.61
https://www.ncbi.nlm.nih.gov/pubmed/16492820 (opens new window)
A systematic review of the use of antifibrinolytic agents in pediatric surgery and implications for craniofacial use. (opens new window)
Avots: Pediatr Surg Int 2012;28(11):1059-69.
Raksts indeksēts: PubMed 22940882
DOI: 10.1007/s00383-012-3167-6
https://www.ncbi.nlm.nih.gov/pubmed/22940882 (opens new window)
Aprotinin, transfusions, and kidney injury in neonates and infants undergoing cardiac surgery. (opens new window)
Avots: Br J Anaesth 2012;108(5):830-7.
Raksts indeksēts: PubMed 22362670
DOI: 10.1093/bja/aes002
https://www.ncbi.nlm.nih.gov/pubmed/22362670 (opens new window)
Comparison of epsilon aminocaproic acid and tranexamic acid in pediatric cardiac surgery. (opens new window)
Avots: J Cardiothorac Vasc Anesth 2004;18(2):141-3.
Raksts indeksēts: PubMed 15073700
https://www.ncbi.nlm.nih.gov/pubmed/15073700 (opens new window)
Efficacy of aprotinin, epsilon aminocaproic acid, or combination in cyanotic heart disease. (opens new window)
Avots: Ann Thorac Surg 2000;70(4):1308-12.
Raksts indeksēts: PubMed 11081890
https://www.ncbi.nlm.nih.gov/pubmed/11081890 (opens new window)
The Bayer 022 compassionate-use pediatric study. (opens new window)
Avots: Ann Thorac Surg 1998;65(6 Suppl):S31-3.
Raksts indeksēts: PubMed 9647135
https://www.ncbi.nlm.nih.gov/pubmed/9647135 (opens new window)
Differential effects of aprotinin and tranexamic acid on outcomes and cytokine profiles in neonates undergoing cardiac surgery. (opens new window)
Avots: J Thorac Cardiovasc Surg 2012;143(5):1069-76.
Raksts indeksēts: PubMed 22075061
DOI: 10.1016/j.jtcvs.2011.08.051
https://www.ncbi.nlm.nih.gov/pubmed/22075061 (opens new window)
Minimizing perioperative blood loss and transfusions in children. [Réduire les pertes sanguines et les besoins transfusionnels en chirurgie pédiatrique.] [English, French abstract] (opens new window)
Avots: Can J Anaesth 2006;53(6 Suppl):S59-67.
Raksts indeksēts: PubMed 16766791
https://www.ncbi.nlm.nih.gov/pubmed/16766791 (opens new window)
Intraoperative tranexamic acid in pediatric bloodless cardiac surgery. (opens new window)
Avots: Asian Cardiovasc Thorac Ann 2014;22(9):1039-45.
Raksts indeksēts: PubMed 24637029
DOI: 10.1177/0218492314527991
https://www.ncbi.nlm.nih.gov/pubmed/24637029 (opens new window)
The safety and efficacy of antifibrinolytic therapy in neonatal cardiac surgery. (opens new window)
Avots: PLoS One 2015;10(5):e0126514.
Raksts indeksēts: PubMed 25954976
DOI: 10.1371/journal.pone.0126514
https://www.ncbi.nlm.nih.gov/pubmed/25954976 (opens new window)
Epsilon aminocaproic acid reduces blood transfusion and improves the coagulation test after pediatric open-heart surgery: a meta-analysis of 5 clinical trials. (opens new window)
Avots: Int J Clin Exp Pathol 2015;8(7):7978-87.
Raksts indeksēts: PubMed 26339364
https://www.ncbi.nlm.nih.gov/pubmed/26339364 (opens new window)
Tranexamic acid versus ɛ-aminocaproic acid: efficacy and safety in paediatric cardiac surgery. (opens new window)
Avots: Eur J Cardiothorac Surg 2011;39(6):892-7.
Raksts indeksēts: PubMed 21115357
DOI: 10.1016/j.ejcts.2010.09.041
https://www.ncbi.nlm.nih.gov/pubmed/21115357 (opens new window)
Replacement of aprotinin by ε-aminocaproic acid in infants undergoing cardiac surgery: consequences for blood loss and outcome. (opens new window)
Avots: Br J Anaesth 2013;110(4):615-21.
Raksts indeksēts: PubMed 23213034
DOI: 10.1093/bja/aes430
https://www.ncbi.nlm.nih.gov/pubmed/23213034 (opens new window)
Hematologic and economic impact of aprotinin in reoperative pediatric cardiac operations. (opens new window)
Avots: Ann Thorac Surg 1998;66(2):535-40; discussion 541.
Raksts indeksēts: PubMed 9725399
https://www.ncbi.nlm.nih.gov/pubmed/9725399 (opens new window)
Efficacy of tranexamic acid as compared to aprotinin in open heart surgery in children. (opens new window)
Avots: Ann Card Anaesth 2015;18(1):23-6.
Raksts indeksēts: PubMed 25566706
DOI: 10.4103/0971-9784.148316
https://www.ncbi.nlm.nih.gov/pubmed/25566706 (opens new window)
Comparative analysis of antifibrinolytic medications in pediatric heart surgery. (opens new window)
Avots: J Thorac Cardiovasc Surg 2012;143(3):550-7.
Raksts indeksēts: PubMed 22264414
DOI: 10.1016/j.jtcvs.2011.06.048
https://www.ncbi.nlm.nih.gov/pubmed/22264414 (opens new window)
The efficacy of tranexamic acid versus placebo in decreasing blood loss in pediatric patients undergoing repeat cardiac surgery. (opens new window)
Avots: Anesth Analg 1997;84(5):990-6.
Raksts indeksēts: PubMed 9141920
https://www.ncbi.nlm.nih.gov/pubmed/9141920 (opens new window)
Effective tranexamic acid concentration for 95% inhibition of tissue-type plasminogen activator induced hyperfibrinolysis in children with congenital heart disease: A prospective, controlled, in-vitro study. (opens new window)
Avots: Eur J Anaesthesiol 2015;32(12):844-50.
Raksts indeksēts: PubMed 26258658
DOI: 10.1097/EJA.0000000000000316
https://www.ncbi.nlm.nih.gov/pubmed/26258658 (opens new window)
Comparison of different doses of ε-aminocaproic acid in children for tetralogy of Fallot surgery: clinical efficacy and safety. (opens new window)
Avots: J Cardiothorac Vasc Anesth 2013;27(1):23-9.
Raksts indeksēts: PubMed 22995453
DOI: 10.1053/j.jvca.2012.07.001
https://www.ncbi.nlm.nih.gov/pubmed/22995453 (opens new window)
Comparison of three dose regimens of aprotinin in infants undergoing the arterial switch operation. (opens new window)
Avots: Ann Card Anaesth 2010;13(2):110-5.
Raksts indeksēts: PubMed 20442540
DOI: 10.4103/0971-9784.62935
https://www.ncbi.nlm.nih.gov/pubmed/20442540 (opens new window)
Pharmacokinetics of tranexamic acid in neonates, infants, and children undergoing cardiac surgery with cardiopulmonary bypass. (opens new window)
Avots: Anesthesiology 2015;122(4):746-58.
Raksts indeksēts: PubMed 25585004
DOI: 10.1097/ALN.0000000000000570
https://www.ncbi.nlm.nih.gov/pubmed/25585004 (opens new window)
Efficacy and safety of aprotinin in neonatal congenital heart operations. (opens new window)
Avots: Ann Thorac Surg 2011;92(3):958-63.
Raksts indeksēts: PubMed 21871283
DOI: 10.1016/j.athoracsur.2011.04.094
https://www.ncbi.nlm.nih.gov/pubmed/21871283 (opens new window)
The effect of preoperative tranexamic acid on blood loss after cardiac operations in children. (opens new window)
Avots: J Thorac Cardiovasc Surg 1996;111(5):982-7.
Raksts indeksēts: PubMed 8622323
https://www.ncbi.nlm.nih.gov/pubmed/8622323 (opens new window)
Aktivēts rekombinants VII faktors (rFVIIa)
Recombinant factor seven therapy for postoperative bleeding in neonatal and pediatric cardiac surgery. (opens new window)
Avots: Ann Thorac Surg 2007;84(1):161-8.
Raksts indeksēts: PubMed 17588404
DOI: 10.1016/j.athoracsur.2007.02.051
https://www.ncbi.nlm.nih.gov/pubmed/17588404 (opens new window)
Pediatric off-label use of recombinant factor VIIa. (opens new window)
Avots: Pediatrics 2009;123(3):1066-72.
Raksts indeksēts: PubMed 19255041
DOI: 10.1542/peds.2008-1685
https://www.ncbi.nlm.nih.gov/pubmed/19255041 (opens new window)
Factor VII for excessive bleeding following congenital heart disease surgery. (opens new window)
Avots: Asian Cardiovasc Thorac Ann 2012;20(2):120-5.
Raksts indeksēts: PubMed 22499956
DOI: 10.1177/0218492311433614
https://www.ncbi.nlm.nih.gov/pubmed/22499956 (opens new window)
Use of recombinant factor VIIa for uncontrolled bleeding in neonates after cardiopulmonary bypass. (opens new window)
Avots: Paediatr Anaesth 2009;19(4):364-70.
Raksts indeksēts: PubMed 19143947
DOI: 10.1111/j.1460-9592.2008.02905.x
https://www.ncbi.nlm.nih.gov/pubmed/19143947 (opens new window)
Review of the off-label use of recombinant activated factor VII in pediatric cardiac surgery patients. (opens new window)
Avots: Anesth Analg 2012;115(2):364-78.
Raksts indeksēts: PubMed 22652310
DOI: 10.1213/ANE.0b013e31825aff10
https://www.ncbi.nlm.nih.gov/pubmed/22652310 (opens new window)
Is recombinant activated factor VII effective in the treatment of excessive bleeding after paediatric cardiac surgery? (opens new window)
Avots: Interact Cardiovasc Thorac Surg 2012;15(4):690-4.
Raksts indeksēts: PubMed 22811512
DOI: 10.1093/icvts/ivs309
https://www.ncbi.nlm.nih.gov/pubmed/22811512 (opens new window)
Cardiac surgery without blood products in a Jehovah's Witness child with factor VII deficiency. (opens new window)
Avots: J Cardiothorac Vasc Anesth 2012;26(4):651-3.
Raksts indeksēts: PubMed 21924639
DOI: 10.1053/j.jvca.2011.07.012
https://www.ncbi.nlm.nih.gov/pubmed/21924639 (opens new window)
Use of recombinant activated factor VII for controlling refractory postoperative bleeding in children undergoing cardiac surgery with cardiopulmonary bypass. (opens new window)
Avots: J Cardiothorac Vasc Anesth 2011;25(6):987-94.
Raksts indeksēts: PubMed 21835642
DOI: 10.1053/j.jvca.2011.05.012
https://www.ncbi.nlm.nih.gov/pubmed/21835642 (opens new window)
Increased recombinant activated factor VII use and need for surgical reexploration following a switch from aprotinin to epsilon-aminocaproic acid in infant cardiac surgery. (opens new window)
Avots: J Clin Anesth 2014;26(3):204-11.
Raksts indeksēts: PubMed 24809789
DOI: 10.1016/j.jclinane.2013.10.015
https://www.ncbi.nlm.nih.gov/pubmed/24809789 (opens new window)
Recombinant activated factor VII for hemorrhage after pediatric cardiac surgery. (opens new window)
Avots: Asian Cardiovasc Thorac Ann 2012;20(1):19-23.
Raksts indeksēts: PubMed 22371937
DOI: 10.1177/0218492311432584
https://www.ncbi.nlm.nih.gov/pubmed/22371937 (opens new window)
Recombinant factor VIIa to treat bleeding after cardiac surgery in an infant. (opens new window)
Avots: Pediatr Crit Care Med 2003;4(1):49-51.
Raksts indeksēts: PubMed 12656542
DOI: 10.1097/01.PCC.0000031472.55687.4E
https://www.ncbi.nlm.nih.gov/pubmed/12656542 (opens new window)
Recombinant factor VIIa to control excessive bleeding following surgery for congenital heart disease in pediatric patients. (opens new window)
Avots: J Intensive Care Med 2004;19(5):270-3.
Raksts indeksēts: PubMed 15358945
DOI: 10.1177/0885066604267783
https://www.ncbi.nlm.nih.gov/pubmed/15358945 (opens new window)
Recombinant activated factor VII in cardiac surgery: a systematic review. (opens new window)
Avots: Ann Thorac Surg 2007;83(2):707-14.
Raksts indeksēts: PubMed 17258029
DOI: 10.1016/j.athoracsur.2006.10.033
https://www.ncbi.nlm.nih.gov/pubmed/17258029 (opens new window)
Defining the role of recombinant activated factor VII in pediatric cardiac surgery: where should we go from here? (opens new window)
Avots: Pediatr Crit Care Med 2009;10(5):572-82.
Raksts indeksēts: PubMed 19451849
DOI: 10.1097/PCC.0b013e3181a642d5
https://www.ncbi.nlm.nih.gov/pubmed/19451849 (opens new window)
Decreasing the need for transfusion: infant cardiac surgery using hemodilution and recombinant factor VIIa. (opens new window)
Avots: Pediatr Cardiol 2013;34(1):119-24.
Raksts indeksēts: PubMed 22760694
DOI: 10.1007/s00246-012-0398-1
https://www.ncbi.nlm.nih.gov/pubmed/22760694 (opens new window)
Single-center experience: use of recombinant factor VIIa for acute life-threatening bleeding in children without congenital hemorrhagic disorder. (opens new window)
Avots: Pediatr Hematol Oncol 2008;25(4):301-11.
Raksts indeksēts: PubMed 18484474
DOI: 10.1080/08880010802016904
https://www.ncbi.nlm.nih.gov/pubmed/18484474 (opens new window)
Koagulācijas faktoru koncentrāti
Perioperative monitoring of thromboelastograph on blood protection and recovery for severely cyanotic patients undergoing complex cardiac surgery. (opens new window)
Avots: Artif Organs 2010;34(11):955-60.
Raksts indeksēts: PubMed 21092037
DOI: 10.1111/j.1525-1594.2010.01148.x
https://www.ncbi.nlm.nih.gov/pubmed/21092037 (opens new window)
Plasma fibrinogen concentration is correlated with postoperative blood loss in children undergoing cardiac surgery. A retrospective review. (opens new window)
Avots: Eur J Anaesthesiol 2014;31(6):317-26.
Raksts indeksēts: PubMed 24503704
DOI: 10.1097/EJA.0000000000000043
https://www.ncbi.nlm.nih.gov/pubmed/24503704 (opens new window)
Efficacy and safety of fibrinogen concentrate in surgical patients: a meta-analysis of randomized controlled trials. (opens new window)
Avots: J Cardiothorac Vasc Anesth 2016;30(5):1196-204.
Raksts indeksēts: PubMed 27493092
DOI: 10.1053/j.jvca.2016.04.015
https://www.ncbi.nlm.nih.gov/pubmed/27493092 (opens new window)
Hemostatic effects of fibrinogen concentrate compared with cryoprecipitate in children after cardiac surgery: a randomized pilot trial. (opens new window)
Avots: J Thorac Cardiovasc Surg 2014;148(4):1647-55.
Raksts indeksēts: PubMed 24951020
DOI: 10.1016/j.jtcvs.2014.04.029
https://www.ncbi.nlm.nih.gov/pubmed/24951020 (opens new window)
Four-factor prothrombin complex concentrates in paediatric patients—a retrospective case series. (opens new window)
Avots: Vox Sang 2016;110(3):253-7.
Raksts indeksēts: PubMed 26509839
DOI: 10.1111/vox.12353
https://www.ncbi.nlm.nih.gov/pubmed/26509839 (opens new window)
Desmopresīns
Minimizing perioperative blood loss and transfusions in children. [Réduire les pertes sanguines et les besoins transfusionnels en chirurgie pédiatrique.] [English, French abstract] (opens new window)
Avots: Can J Anaesth 2006;53(6 Suppl):S59-67.
Raksts indeksēts: PubMed 16766791
https://www.ncbi.nlm.nih.gov/pubmed/16766791 (opens new window)
Anesthetic management in a pediatric patient with Noonan syndrome, mastocytosis, and von Willebrand disease: a case report. (opens new window)
Avots: AANA J 2007;75(4):261-4.
Raksts indeksēts: PubMed 17711156
https://www.ncbi.nlm.nih.gov/pubmed/17711156 (opens new window)
Vietējie hemostatiskie līdzekļi
A comprehensive review of topical hemostatic agents: efficacy and recommendations for use. (opens new window)
Avots: Ann Surg 2010;251(2):217-28.
Raksts indeksēts: PubMed 20010084
DOI: 10.1097/SLA.0b013e3181c3bcca
https://www.ncbi.nlm.nih.gov/pubmed/20010084 (opens new window)
Resternotomy in pediatric cardiac surgery: CoSeal initial experience. (opens new window)
Avots: Interact Cardiovasc Thorac Surg 2007;6(1):21-3.
Raksts indeksēts: PubMed 17669759
DOI: 10.1510/icvts.2006.141531
https://www.ncbi.nlm.nih.gov/pubmed/17669759 (opens new window)
Viskoelasticitātes testi, lai noteiktu ķirurģisko vai koagulopātijas asiņošanu
Utility of Sonoclot analysis and tranexamic acid in tetralogy of Fallot patients undergoing intracardiac repair. (opens new window)
Avots: Ann Card Anaesth 2012;15(1):26-31.
Raksts indeksēts: PubMed 22234018
DOI: 10.4103/0971-9784.91477
https://www.ncbi.nlm.nih.gov/pubmed/22234018 (opens new window)
Perioperative monitoring of thromboelastograph on blood protection and recovery for severely cyanotic patients undergoing complex cardiac surgery. (opens new window)
Avots: Artif Organs 2010;34(11):955-60.
Raksts indeksēts: PubMed 21092037
DOI: 10.1111/j.1525-1594.2010.01148.x
https://www.ncbi.nlm.nih.gov/pubmed/21092037 (opens new window)
Thromboelastometry-guided intraoperative haemostatic management reduces bleeding and red cell transfusion after paediatric cardiac surgery. (opens new window)
Avots: Br J Anaesth 2015;114(1):91-102.
Raksts indeksēts: PubMed 25303988
DOI: 10.1093/bja/aeu339
https://www.ncbi.nlm.nih.gov/pubmed/25303988 (opens new window)